New York State Practitioner Education - Medical Use of Marijuana Course
You are not logged in. Only partial content from this topic will be available to you. To view the full content, you must log in to your account. Don't have a login? Register now. Or, check out our Preview.

The Medical Use of Marijuana in Human Immunodeficiency Virus or Acquired Immune Deficiency Syndrome

Among people living with HIV/AIDS (PLWHA), approximately 30% report using cannabinoids for medicinal purposes (1-3). There are decades-worth of anecdotal reports from PLWHA attesting to cannabis’ beneficial effects on mitigating the symptoms of the disease, common co-morbidities, and side effects of treatment, including cachexia, pain, and nausea. However, practitioners who treat PLWHA require sufficient knowledge of the clinical research surrounding the use of medical cannabis among PLWHA in order to develop an evidence-based opinion regarding its use. This report summarizes the high-quality evidence derived from clinical trials and prospective observational research that has investigated the impact of cannabis use on various health outcomes among PLWHA.

Editors' Note: Medical cannabis has become an important area of study in healthcare. Doctors and healthcare professionals must understand the medical, legal, social and political issues to best respond to their patients’ questions and attend to their needs. This content area is not intended to encourage or dissuade the use of medical cannabis, but has been created to provide a balanced portrayal of the research in this area.

Take a quiz or play a crossword related to this syllabus topic.